Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Pollak

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Molecular Cancer Therapeutics|November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Cancer Research|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Molecular Cancer Research : MCR|November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Journal of the National Cancer Institute|December 18, 2012
A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohortsYing Bao, Edward L Giovannucci, Peter Kraft, et al.
Cancer Research|May 21, 2013
Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolismSarah-Maria Fendt, Eric L Bell, Mark A Keibler, et al.
Journal of the National Cancer Institute|November 25, 2015
Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation StatusKentaro Inamura, Mingyang Song, Seungyoun Jung, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2008
A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancerMarc J Gunter, Donald R Hoover, Herbert Yu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 30, 2020
Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized TrialJustin C Brown, Sui Zhang, Jennifer A Ligibel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 7, 2013
Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohortsYing Bao, Edward L Giovannucci, Peter Kraft, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Molecular Cancer Therapeutics|November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Cancer Research|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Molecular Cancer Research : MCR|November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Journal of the National Cancer Institute|December 18, 2012
A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohortsYing Bao, Edward L Giovannucci, Peter Kraft, et al.
Cancer Research|May 21, 2013
Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolismSarah-Maria Fendt, Eric L Bell, Mark A Keibler, et al.
Journal of the National Cancer Institute|November 25, 2015
Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation StatusKentaro Inamura, Mingyang Song, Seungyoun Jung, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2008
A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancerMarc J Gunter, Donald R Hoover, Herbert Yu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 30, 2020
Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized TrialJustin C Brown, Sui Zhang, Jennifer A Ligibel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 7, 2013
Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohortsYing Bao, Edward L Giovannucci, Peter Kraft, et al.
Pageof 18